The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,328.00
Bid: 2,323.00
Ask: 2,325.00
Change: 44.00 (1.93%)
Spread: 2.00 (0.086%)
Open: 2,291.00
High: 2,340.00
Low: 2,284.00
Prev. Close: 2,284.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Jan 2024 07:00

RNS Number : 3498B
Halma PLC
30 January 2024
 

Halma plc ("Halma" or "Company")Directorate Change

 

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Giles Kerr as an independent non-executive Director, with effect from 1 February 2024. Giles will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Giles brings a wealth of experience gained across a variety of roles in life sciences, technology and industrial businesses. Giles has a particularly strong background in driving strategic business growth as well as extensive M&A experience. He is currently Chair of PayPoint plc and was Senior Independent Director & Audit Committee Chair at Abcam plc, until it was acquired by Danaher in December 2023.

 

His executive career included senior financial roles at Arthur Andersen (leading to his appointment as National Partner), Amersham plc (latterly as Group Finance Director) and as Finance Director at Oxford University Innovation. Since 2007, Giles has held a number of non-executive director roles including Elan Corporation, Victrex plc, BTG plc, Oxford Sciences Innovation plc, Arix Bioscience plc and Senior plc.

 

Roy Twite, non-executive Director, who has served for nine years on the Board, will step down as a Director on 7 June 2024.

 

Dame Louise Makin, Chair, commented:"I am delighted that Giles is joining the Halma Board. His extensive executive and non-executive experience, particularly in the life sciences and technology sectors, will bring valuable insights and perspectives to the Board.

 

I would like to thank Roy for his valuable contribution to Halma, and particularly the support that he has given to me and the Board to ensure an orderly transition and onboarding of recent executive and non-executive Directors"

 

There are no further details to be disclosed for Giles Kerr under Listing Rule 9.6.13R.

 

 

For further information, please contact:

Halma plcMarc Ronchetti, Group Chief ExecutiveSteve Gunning, Chief Financial Officer

Charles King, Head of Investor Relations

Clayton Hirst, Director of Corporate Affairs

+44 (0)1494 721 111

+44 (0)7776 685948

+44 (0)7834 796 013

MHPOliver Hughes/Rachel Farrington/Ollie Hoare

+44 (0)20 3128 8100

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGFMVGFGDZG
Date   Source Headline
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.